SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-039487
Filing Date
2020-06-30
Accepted
2020-06-30 16:48:47
Documents
2
Period of Report
2020-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1630
2 POA DOCUMENT poa.txt EX-24.3_925222 3869
  Complete submission text file 0001209191-20-039487.txt   7031
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET 9TH FL STAMFORD CT 06902
Business Address
Shiff Susan Ph.D. (Reporting) CIK: 0001811463 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36279 | Film No.: 201002828